Importantly, the inhibition of JAK2 or STAT5 was shown to induce apoptosis in BCR-ABL1-positive cell lines as well as primary cells derived from imatinib-sensitive or resistant CML patients [45,46,52]. The gene discussed is JAK2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.